NSC |
Compound |
Enrichment |
Correlation |
NSC 676779 |
Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop |
0.03551961774939 |
-0.011120284 |
NSC 677672 |
Null |
0.03551961774939 |
0.29559651 |
NSC 677776 |
Null |
0.03551961774939 |
-0.085918058 |
NSC 678925 |
1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride |
0.03551961774939 |
0.33094102 |
NSC 679001 |
2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- |
0.03551961774939 |
0.23988815 |
NSC 679800 |
Null |
0.03551961774939 |
0.17682362 |
NSC 690118 |
Null |
0.03551961774939 |
-0.060787674 |
NSC 690270 |
ANTINEOPLASTIC-690270 |
0.03551961774939 |
0.094204289 |
NSC 693986 |
Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-5-methyl-3-propynyl-, (E)-, |
0.03551961774939 |
0.22893774 |
NSC 696558 |
N-(4-Amino-4-deoxy-N10-methypteroyl)-D,L-homocysteic acid |
0.03551961774939 |
0.35999118 |